# Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis

> **NCT03302806** · — · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 103 (actual)

## Conditions studied

- Progressive Multiple Sclerosis

## Interventions

- **OTHER:** Non interventional Study

## Key facts

- **NCT ID:** NCT03302806
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-29
- **Primary completion:** 2017-10-04
- **Final completion:** 2018-10-24
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03302806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03302806, "Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03302806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*